ARIA Financial Facts
Interest expense: -49KNet income (loss) per share - basic: 0.1
See Full Income Statement
Other current assets: 1.53M
Property and equipment, net: 5.85M
See Full Balance Sheet
Ariad Pharmaceuticals Inc. (ARIA) Earnings
|
Expand Research on ARIA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +172.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +16.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/7/16  |
 |
Q316 | -$0.12 | -$0.19 | +$0.07 | $34.3M | $42.93M | N/A |  | | Details |
| 7/28/16 |
|
Q216 | $0.59 | -$0.11 | +$0.70 | $65.3M | $60.64M | N/A | | | Details |
| 5/10/16 |
|
Q116 | -$0.23 | -$0.26 | +$0.03 | $35.6M | $43.27M | N/A | | | Details |
| 2/23/16 |
|
Q415 | -$0.32 | -$0.34 | +$0.02 | $36.5M | $34M | N/A | | | Details |
| 11/3/15 |
|
Q315 | -$0.29 | -$0.23 | -$0.06 | $27.5M | $46.09M | N/A | | | Details |
| 8/5/15 |
|
Q215 | -$0.33 | -$0.27 | -$0.06 | $27.8M | $33.24M | N/A | | | Details |
| 5/7/15 |
|
Q115 | -$0.28 | -$0.26 | -$0.02 | $23.9M | $27.26M | N/A | | | Details |
| 2/19/15 |
|
Q414 | -$0.03 | -$0.20 | +$0.17 | $66M | $39.5M | N/A | | | Details |
